Who invested in HLS Therapeutics

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$221Mraised across 3 rounds since 2015, from 3 sources

$113MGrowth$30MVenture$79MDebt

Latest round: Debt, $79MAug 2024
Biggest round: $113MGrowth · Jul 2015
Step-upi: 2.6×
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152017201920212023

$113MGrowth$30MVenture$79MDebt

First round: Growth, $113M
Biggest round: $113M
Usual gap between rounds: 8.9 years

The rounds

Aug 2024
Debt$79M5 new
Source recorded
Aug 2015
Venture$30M
No investor was named in the report.
From a historical funding recordSEC filing: $30M sold, first sale Aug 2015
Jul 2015
Growth$113M
No investor was named in the report.
From a historical funding recordSEC filing: $113M sold, first sale Jul 2015

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Growth2015Venture2015Debt2024

SVB Capital

JP Morgan

JP Morgan Chase

National Bank of Canada

Royal Bank of Canada

Everyone who backed them

SVB CapitalVC firm1round

JP MorganInvestment bank1round

JP Morgan ChaseCorporate VC1round

National Bank of CanadaPrivate equity1round

Royal Bank of CanadaGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists HLS Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.